 |
|
Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
Kyung In Lim, Hae Sang Lee, Jin Soon Hwang
Ann Pediatr Endocrinol Metab. 2020;25(3):169-173. Published online 2020 Sep 30 DOI: https://doi.org/10.6065/apem.1938176.088
|
|
Citations to this article as recorded by
 An Approach to the Evaluation and Management of the Obese Child With Early Puberty
Christine B Tenedero, Krista Oei, Mark R Palmert
Journal of the Endocrine Society.2022;[Epub] CrossRef Body composition in sexual precocity
Elmas Nazli Gonc, Nurgun Kandemir
Current Opinion in Endocrinology, Diabetes & Obesity.2022; 29(1): 78. CrossRef Do GnRH Agonists Really Increase Body Weight Gain? Evaluation of a Multicentric Portuguese Cohort of Patients With Central Precocious Puberty
Ana Luísa Leite, Elisa Galo, Ana Antunes, Brígida Robalo, Daniela Amaral, Filipa Espada, Sofia Castro, Sara Simões Dias, Catarina Limbert
Frontiers in Pediatrics.2022;[Epub] CrossRef Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study
Ming-ming Ni, Shu-ting Yang, Wen-wen Wu, Shan-shan Wang, Man Li, Qing-qing Liu, Xing Ji
BMC Endocrine Disorders.2022;[Epub] CrossRef Use of gonadotropin-releasing hormone analogs in children
Natalie G. Allen, Kanthi Bangalore Krishna, Peter A. Lee
Current Opinion in Pediatrics.2021; 33(4): 442. CrossRef Genetic etiologies of central precocious puberty
Hae Sang Lee
Precision and Future Medicine.2021; 5(3): 117. CrossRef
|